Achillion Pharma Stock Price (NASDAQ:ACHN)

Add to My Stocks
$3.2 $0.13 (4.23%) ACHN stock closing price Feb 16, 2018 (Closing)
Prev Close* : $3.07
Market Cap:
$441.14M
Day Low: $3.07
52 Week Low: $2.58
Open: $3.1
Volume: -
Day High: $3.24
52 Week High: $5.66
Dividend:
0.00

Latest Stock Market News

Latest Articles

Achillion Pharma News - From Partners

ACHN Stockcharts

View ACHN PE ratio, PS ratio stocks charts and compare with peers.
ACHN Chart
Note: Compare Achillion Pharma stock price history with the index and industry peers.

Achillion Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Achillion Pharma Returns

ROE
(return on equity)
-18%

Achillion Pharma Financial Ratios

Asset Turnover
0
Receivables Turnover
4.52
Debt to Equity
0
Dividend Yield
-999.0000

ACHN Industry Peers

Company Price Change (%)
Heska (HSKA)61.050.45 (0.74%)
Edge Therapeautics (EDGE)13.950.05 (0.36%)
Biocryst Pharma (BCRX)4.960.09 (1.85%)
Enanta Pharma (ENTA)81.580.24 (0.3%)
Merck (MRK)56.290.3 (0.54%)
Nanoviricides (NNVC)10.02 (2.04%)
Abbvie (ABBV)118.63.7 (3.22%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)2.340.18 (8.33%)
Fate Therapeutics (FATE)8.760.65 (8.01%)
Dicerna Pharma (DRNA)10.630.57 (5.67%)
Alkermes (ALKS)67.263.51 (5.51%)
AVID BIOSERVICS (CDMO)2.490.12 (5.06%)
Achillion Pharma (ACHN)3.20.13 (4.23%)
NewLink Genetics (NLNK)7.110.27 (3.95%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Cytokinetics (CYTK)8.0250.63 (7.28%)
MiMedx (MDXG)14.470.96 (6.22%)
Catalyst Biosciences (CBIO)31.082.01 (6.07%)
Advaxis (ADXS)2.510.13 (4.92%)
Insmed (INSM)24.231.14 (4.49%)
Amicus Therapeutics (FOLD)15.170.66 (4.17%)
Alder BioPharma (ALDR)13.550.5 (3.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018

Achillion Pharmaceuticals, Inc. Stock News - Partner Headlines

Achillion Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues15M66.12M--2.6M
Net Income-61.7M-5.03M-69M-58.94M-47.12M
Total Operating Expense79.86M81.22M69.42M59.47M49.89M
View Achillion Pharma income statement
balance sheet20162015201420132012
Total Assets413.87M464.52M156.8M162.41M81.53M
Total Liabilities14.42M14.88M13.33M9.45M9.48M
Shareholders Equity399.45M449.63M143.46M152.95M72.04M
View Achillion Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-16.33M-4.71M--3.43M
Net Cash from (used by) Operating Activities-65.65M5.57M-55.52M-53.63M-46.53M
Increase (Decrease) in Prop Plant And Equipment-2.5M-0.7M-0.94M-0.4M-0.65M
View Achillion Pharma cash flow statement

Achillion Pharma Stock Message Board

An investor needs to spend $3.2 to buy ACHN stock, as the closing Achillion Pharma stock price is $3.2. The total market value as denoted by $441.14M for Achillion Pharma, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Achillion Pharma valuation, even though in the short-term, sentiment and current breaking news might affect Achillion Pharma stock price.

The terms stocks and shares mean the same thing. For Ex: Achillion Pharma stock price and Achillion Pharma share price mean the same thing. The volume of shares traded stood at 8,034,929 on the last trading day, as is evident from Achillion Pharma stock chart, and ACHN stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Achillion Pharma dividend per share was 0.00 during the last quarter. Achillion Pharma stock price history, gives the entire historical data for ACHN stock.